Balance Sheet
Accounts PayablesAccumulated ExpensesCommon EquityConvertible DebtLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsPayablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Medicale (MCLE) Liabilities and Shareholders Equity (2020 - 2024)

Medicale's Liabilities and Shareholders Equity history spans 5 years, with the latest figure at $159.0 for Q4 2024.

  • For Q4 2024, Liabilities and Shareholders Equity changed 0.0% year-over-year to $159.0; the TTM value through Sep 2025 reached $159.0, down 75.0%, while the annual FY2024 figure was $159.0, 0.0% changed from the prior year.
  • Liabilities and Shareholders Equity reached $159.0 in Q4 2024 per MCLE's latest filing, roughly flat from $159.0 in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $34900.0 in Q1 2021 to a low of $159.0 in Q4 2022.
  • Average Liabilities and Shareholders Equity over 5 years is $7035.3, with a median of $159.0 recorded in 2022.
  • Peak YoY movement for Liabilities and Shareholders Equity: rose 8.44% in 2021, then plummeted 98.74% in 2022.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $11600.0 in 2020, then rose by 8.44% to $12579.0 in 2021, then plummeted by 98.74% to $159.0 in 2022, then changed by 0.0% to $159.0 in 2023, then changed by 0.0% to $159.0 in 2024.
  • Per Business Quant, the three most recent readings for MCLE's Liabilities and Shareholders Equity are $159.0 (Q4 2024), $159.0 (Q3 2024), and $159.0 (Q2 2024).